Page last updated: 2024-08-23

miglustat and Adverse Drug Event

miglustat has been researched along with Adverse Drug Event in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W	1
Banwell, B; Clarke, JT; Dingemanse, J; Maegawa, GH; Morgan, CP; Tifft, CJ; van Giersbergen, PL; Yang, S	1
Belmatoug, N; Burlina, A; Giraldo, P; Hendriksz, CJ; Kuter, DJ; Mengel, E; Pastores, GM	1
Aerts, JF; Altarescu, G; Attias, D; Dweck, A; Elstein, D; Hadas-Halpern, I; van Weely, S; Zevin, S; Zimran, A	1

Reviews

1 review(s) available for miglustat and Adverse Drug Event

Article	Year
Gastrointestinal disturbances and their management in miglustat-treated patients. Journal of inherited metabolic disease, 2011, Volume: 34, Issue:5 Topics: 1-Deoxynojirimycin; Adult; Child; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Gastrointestinal Diseases; Gaucher Disease; Humans; Models, Biological	2011

Trials

2 trial(s) available for miglustat and Adverse Drug Event

Article	Year
Pharmacokinetics, safety and tolerability of miglustat in the treatment of pediatric patients with GM2 gangliosidosis. Molecular genetics and metabolism, 2009, Volume: 97, Issue:4 Topics: 1-Deoxynojirimycin; Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Gangliosidoses, GM2; Glucosyltransferases; Humans; Infant	2009
Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement. Blood, 2007, Oct-01, Volume: 110, Issue:7 Topics: 1-Deoxynojirimycin; Administration, Oral; Adolescent; Adult; Aged; Drug-Related Side Effects and Adverse Reactions; Female; Gaucher Disease; Glucosylceramidase; Humans; Injections, Intravenous; Male; Middle Aged; Quality of Life; Time Factors	2007

Article

Year

Pharmacokinetics, safety and tolerability of miglustat in the treatment of pediatric patients with GM2 gangliosidosis.

Molecular genetics and metabolism, 2009, Volume: 97, Issue:4

Topics: 1-Deoxynojirimycin; Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Gangliosidoses, GM2; Glucosyltransferases; Humans; Infant

2009

Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement.

Blood, 2007, Oct-01, Volume: 110, Issue:7

Topics: 1-Deoxynojirimycin; Administration, Oral; Adolescent; Adult; Aged; Drug-Related Side Effects and Adverse Reactions; Female; Gaucher Disease; Glucosylceramidase; Humans; Injections, Intravenous; Male; Middle Aged; Quality of Life; Time Factors

2007

Other Studies

1 other study(ies) available for miglustat and Adverse Drug Event

Article	Year
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology, 2011, Volume: 7, Issue:12 Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests	2011

Article

Year

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology, 2011, Volume: 7, Issue:12

Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011